Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Jayapal, Pramila [D-WA-7]

Rep. Jayapal, Pramila [D-WA-7]

United States · Official source

Records

3,378 records where Rep. Jayapal, Pramila [D-WA-7] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 9662 (118th)referred

Homes Act of 2024

United States · United States Congress · 18 September 2024

Bill· HRH.R. 9639 (118th)referred

AI Ads Act

United States · United States Congress · 17 September 2024

Bill· HRH.R. 9262 (118th)referred

Bivens Act of 2024

United States · United States Congress · 2 August 2024

Bill· HRH.R. 9244 (118th)referred

NO BAN Act

United States · United States Congress · 2 August 2024

Bill· HRH.R. 9156 (118th)referred

Health Over Wealth Act

United States · United States Congress · 25 July 2024

Bill· HRH.R. 8886 (118th)referred

CHARTER Act

United States · United States Congress · 28 June 2024

Resolution· HRESH.Res. 1332 (118th)referred

Original LGBTQIA+ Pride Month Resolution of 2024

United States · United States Congress · 28 June 2024

This resolution states that the House of Representatives recognizes that (1) lesbian, gay, bisexual, transgender, queer, intersex, and asexual (LGBTQIA+) rights are human rights and protected by the U.S. Constitution; (2) LGBTQIA+ Pride Month should be celebrated; and (3) all U.S. citizens should be treated equally regardless of sexual orientation, sex characteristics, or gender identity. 

Bill· HRH.R. 8796 (118th)referred

Stop Comstock Act.

United States · United States Congress · 21 June 2024

Bill· HRH.R. 8797 (118th)referred

Ending Corporate Greed Act

United States · United States Congress · 21 June 2024

Ending Corporate Greed Act  This bill imposes a tax through 2026 on certain corporations (corporations other than regulated investment companies, real estate investment trusts, or S corporations) that have average annual gross receipts for a three-year period of at least $500 million. The tax is 95% of what are deemed excess profits for a taxable year.